Even more than for other treatments, great importance must be given to informed consent in the case of electroconvulsive therapy (ECT). In a percentage of cases, the symbolic connotation of the treatment, even if mostly and intrinsically negative, may actually be a determining factor in the patient’s motives for giving consent. On an ethical and medicolegal level, the most critical point is that concerning consent to the treatment by a psychotic subject with a severely compromised ability to comprehend the nature and objective of the proposed therapy, but who nonetheless expresses his consent, for reasons derived from delusional thoughts. In fact, this situation necessarily brings to light the contradiction between an explicit expression of consent, a necessary formality for the commencement of therapy, and the validity of this consent, which may be severely compromised due to the patient’s inability to comprehend reality and therefore to accept the proposal of treatment, which is intrinsic to this reality. With the use of an electric current, the symbolic experience associated with anaesthesia, and the connection to convulsions, ECT enters the collective consciousness. In relation to this, ECT is symbolic of these three factors and hooks on to the thoughts, fears, feelings and expectations of delusional patients. These are often exemplified in the violent intervention of the persecutor in the patient with schizophrenia, the expected punishment for the ’error’ committed for which the depressed patient blames himself and the social repression of the maniacal patient’s affirmation of his inflated self-esteem.
- electrical stimulation of the brain
- clinical ethics
- informed consent
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Contributors GB wrote the first part of the article related to the 'informed consent'. AI and FP wrote the second part of the article related to the 'ECT'. All three authors conceived and wrote the conclusions.
Funding This study has been supported by the Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila. AI is a recipient of a research grant (SSD MED/25, Rep. n. 43/2017, Prot. n. 685 del 19.7.2017).
Competing interests None declared.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; externally peer reviewed.
Read the full text or download the PDF:
Other content recommended for you
- Electroconvulsive therapy: a life course approach for recurrent depressive disorder
- Electroconvulsive therapy, catatonia, deep vein thrombosis and anticoagulant treatment: a case report
- Catatonic schizophrenia: therapeutic challenges and potentially a new role for electroconvulsive therapy?
- Informed consent and ECT: how much information should be provided?
- Electroconvulsive therapy, the placebo effect and informed consent
- Current status of electroconvulsive therapy for mood disorders: a clinical review
- New guidance on ECT looks set to curb its use
- Complete cognitive recovery in a severe case of anti-N-methyl-d-aspartate receptor encephalitis treated with electroconvulsive therapy
- Successful electroconvulsive therapy for depression in a man with cerebral amyloid angiopathy
- Worsening of movement disorder following treatment with electroconvulsive therapy in a patient with Huntington’s disease